Automated Cell Culture System Market Size, Forecast, and Trend Highlights Over 2023

Major Macro-Economic Indicators Impacting the Market Growth

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Get more information on this report: Request Free Sample PDF

Global Automated Cell Culture System Market: Growth Drivers and Challenges

Growth Drivers

Significant Demand in the Treatment of Skin Problems - In 2022, over 6 million Americans were found to be living with psoriasis while about 200 million were across the globe.

The cell culture system puts regenerative medicines in use for patients practically. Cells are used by regenerative medicines in the form of therapeutic agents which are required for the medical treatment associated with repairing, rebuilding, and making the human body function properly. Hence such a significant utilization is estimated to propel the market growth over the forecast period.

Rising Cases of Non-Communicable Diseases - Data published by the World Health Organization showed that nearly 41 million individuals die due to non-communicable diseases every year.
Higher Prevalence of Infectious Diseases - The annual rate of death caused by infectious diseases is estimated to be more than 15 million a year.
Growing Healthcare Expenditure Across the Globe - As per the statistics provided by the World Bank, global health expenditure was estimated to reach USD 1,121.9 per capita.
Increasing Number of Clinical Trials - As of 2021, the number of clinical trials is estimated to be nearly 0.4 million in about 200 countries.

Challenges

Lack of Skilled Medical Professionals
Lack of Required Technology to Develop the Cell Culture System
Requirement for Higher Initial Investment

The global automated cell culture system market is segmented and analyzed for demand and supply by end-user into academic institutes, biotech company, and research organization, out of which, the biotech company segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted to the rising activities of research and development across the globe. For instance, the biotech industry was valued at approximately USD 450 billion in 2020.

On the other, on the basis of mode of delivery, automated cell culture system market is segmented into topical application, aerial diffusion, and direct inhalation. Out of all these, the topical application garnered the highest market share i.e. 41.03% in 2022. The rising technological advancements along with the huge investments made in the healthcare sector is expected to bring lucrative opportunities for the segment growth.

Global Automated Cell Culture System Market Regional Synopsis

Regionally, the global automated cell culture system market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America region holds the largest market share with 42.16% in 2022. The growth of the market is attributed to rising investment in research and development in the region. The National Cancer Institute (NIC) published statistics showing that the NCI budget to make funding for research for cancer reached USD 6440.4 million in 2020. Additionally, the higher prevalence of chronic diseases and the presence of major key players in the region is further expected to propel the growth of the market over the forecast period. Furthermore, the Europe region is also estimated to provide a lucrative opportunity for the market to grow exponentially.

Automated-Cell-Culture-System-Market-Demand-Analysis-Future

The global automated cell culture system market is further classified on the basis of region as follows:

North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global automated cell culture system market includes the following segments:

By Product Type	Consumables Bioreactors Equipment
By Line Culture	Finite Cell Infinite Cell
By Application	Drug Development Stem Cell & Cancer Research Regenerative Medicine
By Mode of Delivery	Topical Application – 41.03% Aerial Diffusion – 23.5% Direct Inhalation – 35.5%
By End-User	Academic Institutes Biotech Company Research Organization

Get more information on this report: Request Free Sample PDF

Top Featured Companies Dominating the Global Automated Cell Culture System Market

Hitachi Power Solutions Co, Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Lonza Group Ltd.
Thermo Fisher Scientific Company
Cell Culture Company, LLC
Sartorius AG
Becton, Dickinson and Company
Hamilton Company
Merck Group
F. Hoffmann-La Roche AG
Novartis AG

In The News

Hitachi Power Solutions Co., Ltd. to launch FineSAT7, a scanning acoustic tomograph with higher image quality. this scanning acoustic tomograph is used to detect particular defects in the body with help of transmissive and reflective properties of ultrasonic waves.
Becton, Dickinson and Company to start the enrollment for the first-in-human trial for sirolimus drug-coated balloons (DCB). The company is conducting these trials to improve the treatment option for peripheral arterial diseases.

Global Economic Impact

Request Insights

Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Key Questions Answered in the Report

1) What are the major factors driving the growth of the automated cell culture system market?

Ans: Increasing stem cell research & development owing to the higher prevalence of related diseases is estimated to majorly boost the market growth.

2) What would be the CAGR of automated cell culture system market over the forecast period?

Ans: The market is anticipated to attain a CAGR of ~12.4% over the forecast period, i.e., 2023 – 2033.

3) What are the challenges affecting the automated cell culture system market growth?

Ans: The lack of required technology to develop the cell culture system is estimated to challenge the market growth.

4) Which region will provide more business opportunities for growth of automated cell culture system market in future?

Ans: The market in North America – 42.16% holds the largest market share in 2022 and will provide more business opportunities in the future.

5) Who are the major players dominating the automated cell culture system market?

Ans: The major players in the market are Lonza Group Ltd., Thermo Fisher Scientific Company, Cell Culture Company, LLC, Sartorius AG, Becton, Dickinson and Company, Hamilton Company, Merck Group, and others.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the automated cell culture system market?

Ans: The market is segmented by product type, line culture, application, mode of delivery, end-user, by region.

8) Which segment captures the largest market size in end-user in the automated cell culture system market?

Ans: The topical application segment – 41.03% holds the largest market size in 2022 and display significant growth opportunities.